Investigating the Presence of Inflammation in Lateral Epicondylitis with Platelet/Lymphocyte Ratio, Neutrophil/Lymphocyte Ratio, and Systemic Immune-Inflammation Index
Investigating the Presence of Inflammation in Lateral Epicondylitis
DOI:
https://doi.org/10.5281/zenodo.7718532Keywords:
Lateral epicondylitis, systemic immune-inflammation index, neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, inflammationAbstract
Aim: This study aims to assess the existence of inflammation in the physiopathology of lateral epicondylitis (LE) and to evaluate the levels of blood inflammation parameters.
Material and Method: 72 patients with LE and 50 healthy individuals were included in this retrospective study. Age, gender, erythrocyte sedimentation rate (ESR), neutrophil, white blood cell (WBC), C-reactive protein (CRP), lymphocyte, platelet counts, platelet-lymphocyte ratio (PLR), neutrophil-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII) levels were scanned retrospectively from the hospital information system.
Results: While the patient and control groups were similar in terms of gender, age, CRP, ESR, lymphocyte, NLR and PLR values (p=0.902, p=0.108, p=0.193, p=0.902, p=0.523, p=0.140 and p=0.253, respectively), the median value of neutrophils, mean platelet, mean WBC and median SII score parameters were higher in the patient group (P=0.022, p=0.037, p=0.037, p=0.038, respectively). A strong correlation was detected between SII and NLR and PLR (both p<0.001, r:0.833 and r:0.778, respectively). The area under the curve (AUC) was calculated as 0.61 for SII via the receiver operating characteristics (ROC) curve analysis, (p=0,038).
Conclusion: The SII value, which is an indicator of inflammation, was more elevated in the LE group compared to the healthy group. More study is needed on this subject.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Chronicles of Precision Medical Researchers
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.